COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,556 Articles (22,881 medRxiv, 8,675 bioRxiv)

Most recent first Previous |  Page 2893: Articles 28921-28930  | Next

Mental Health of Clinical Staff Working in High-Risk Epidemic and Pandemic Health Emergencies: A Rapid Review of the Evidence and Meta-Analysis
Bell, V., Wade, D.
10.1101/2020.04.28.20082669 — Posted: 2020-05-02
SARS-CoV-2 is well adapted for humans. What does this mean for re-emergence?
Zhan, S. H., Deverman, B. E., Chan, Y. A.
10.1101/2020.05.01.073262 — Posted: 2020-05-02 Discussion: Onsite | Offsite
CoV-Seq: SARS-CoV-2 Genome Analysis and Visualization
Liu, B., Liu, K., Zhang, H., Zhang, L., Huang, L.
10.1101/2020.05.01.071050 — Posted: 2020-05-02
Structural and Functional Implications of Non-synonymous Mutations in the Spike protein of 2,954 SARS-CoV-2 Genomes
Nelson-Sathi, S., Perunthottathu K, U., Easwaran, S., Nair, R. R., Joseph, I., Nori, S. R. C., Philip, J. S., Prasad, R., Kolaparamba, K. V., Ramesh, S., Pillai, H., Gosh, S., TR, S. K., Pillai, M. R.
10.1101/2020.05.02.071811 — Posted: 2020-05-02
An artificial intelligence system reveals liquiritin inhibits SARS-CoV-2 by mimicking type I interferon
Zhu, J., Deng, Y.-Q., Wang, X., Li, X.-F., Zhang, N.-N., Liu, Z., Zhang, B., Qin, C., Xie, Z.
10.1101/2020.05.02.074021 — Posted: 2020-05-02 Discussion: Offsite
PSGL-1 blocks SARS-CoV-2 S protein-mediated virus attachment and infection of target cells
He, S., Hetrick, B., Dabbagh, D., Akhrymuk, I. V., Kehn-Hall, K., Freed, E. O., Wu, Y.
10.1101/2020.05.01.073387 — Posted: 2020-05-02
Release of potential pro-inflammatory peptides from SARS-CoV-2 spike glycoproteins in neutrophil-extracellular traps
Blanco-Miguez, A., Sanchez, B.
10.1101/2020.05.02.072439 — Posted: 2020-05-02 Discussion: Onsite | Offsite
Functional pathways in respiratory tract microbiome separate COVID-19 from community-acquired pneumonia patients
Haiminen, N., Utro, F., PARIDA, L.
10.1101/2020.05.01.073171 — Posted: 2020-05-02
Rapid adaptation of SARS-CoV-2 in BALB/c mice: Novel mouse model for vaccine efficacy
Gu, H., Chen, Q., Yang, G., He, L., Fan, H., Deng, Y.-q., Wang, Y., Teng, Y., Zhao, Z., Cui, Y., Li, Y., Li, X.-F., Li, J., Zhang, N., Yang, X., Chen, S., Zhao, G., Wang, X., Luo, D., Wang, H., Yang, X., Li, Y., Han, G., He, Y., Zhou, X., Geng, S., Sheng, X., Shi, B., Sun, S., Qin, C.-F., Zhou, Y.
10.1101/2020.05.02.073411 — Posted: 2020-05-02 Discussion: Onsite
Identification of Drugs Blocking SARS-CoV-2 Infection using Human Pluripotent Stem Cell-derived Colonic Organoids
Duan, X., Han, Y., Yang, L., Nilsson, B., Wang, P., Zhang, T., Wang, X., Xu, D., Xiang, J. Z., uhl, s., Huang, Y., Chen, H., Wang, H., tenOever, B. R., Schwartz, R. E., Ho, D. D., Pan, F. C., Chen, S., Evans, T. R.
10.1101/2020.05.02.073320 — Posted: 2020-05-02 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).